Found: 45
Select item for more details and to access through your institution.
Transgenic expression of IL-7 regulates CAR-T cell metabolism and enhances in vivo persistence against tumor cells.
- Published in:
- Scientific Reports, 2022, v. 12, n. 1, p. 1, doi. 10.1038/s41598-022-16616-2
- By:
- Publication type:
- Article
Advances in multiple omics of natural-killer/T cell lymphoma.
- Published in:
- Journal of Hematology & Oncology, 2018, v. 11, n. 1, p. N.PAG, doi. 10.1186/s13045-018-0678-1
- By:
- Publication type:
- Article
Mechanism of Inhibiting the Cell Growth in Diffuse Large B-cell Lymphoma by Valproic Acid Combined with Temsirolimus.
- Published in:
- Journal of Experimental Hematology / Zhongguo Shiyan Xueyexue Zazhi, 2013, v. 21, n. 6, p. 1441, doi. 10.7534/j.issn.1009-2137.2013.06.014
- By:
- Publication type:
- Article
Loss of promoter methylation contributes to the expression of functionally impaired PRDM1β isoform in diffuse large B-cell lymphoma.
- Published in:
- 2010
- By:
- Publication type:
- journal article
Advances in targeted therapy for malignant lymphoma.
- Published in:
- Signal Transduction & Targeted Therapy, 2020, v. 5, n. 1, p. 1, doi. 10.1038/s41392-020-0113-2
- By:
- Publication type:
- Article
Impact of Vitamin E Supplementation on High‐Density Lipoprotein in Patients With Haptoglobin Genotype–Stratified Diabetes: A Systematic Review of Randomized Controlled Trials.
- Published in:
- Journal of Diabetes Research, 2024, v. 2024, p. 1, doi. 10.1155/2024/6645595
- By:
- Publication type:
- Article
MicroRNA181a Is Overexpressed in T-Cell Leukemia/Lymphoma and Related to Chemoresistance.
- Published in:
- 2015
- By:
- Publication type:
- journal article
A novel SLC1A1‐RIC1 fusion sensitive to asparaginase‐based therapy in natural killer/T‐cell lymphoma.
- Published in:
- British Journal of Haematology, 2023, v. 203, n. 3, p. 485, doi. 10.1111/bjh.19066
- By:
- Publication type:
- Article
GSTT1 Deletion Is Related to Polycyclic Aromatic Hydrocarbons-Induced DNA Damage and Lymphoma Progression.
- Published in:
- PLoS ONE, 2014, v. 9, n. 2, p. 1, doi. 10.1371/journal.pone.0089302
- By:
- Publication type:
- Article
Pretreatment Liver Injury Predicts Poor Prognosis of DLBCL Patients.
- Published in:
- Mediators of Inflammation, 2017, p. 1, doi. 10.1155/2017/7960907
- By:
- Publication type:
- Article
CircEAF2 counteracts Epstein-Barr virus-positive diffuse large B-cell lymphoma progression via miR-BART19-3p/APC/β-catenin axis.
- Published in:
- Molecular Cancer, 2021, v. 20, n. 1, p. 1, doi. 10.1186/s12943-021-01458-9
- By:
- Publication type:
- Article
MiR155 sensitized B-lymphoma cells to anti-PD-L1 antibody via PD-1/PD-L1-mediated lymphoma cell interaction with CD8+T cells.
- Published in:
- Molecular Cancer, 2019, v. 18, n. 1, p. N.PAG, doi. 10.1186/s12943-019-0977-3
- By:
- Publication type:
- Article
18F-FDG PET/CT metrics-based stratification of large B-cell lymphoma receiving CAR-T cell therapy: immunosuppressive tumor microenvironment as a negative prognostic indicator in patients with high tumor burden.
- Published in:
- 2024
- By:
- Publication type:
- Letter
Dynamic change of soluble interleukin-2 receptor distinguished molecular heterogeneity and microenvironment alterations in diffuse large B-cell lymphoma.
- Published in:
- Biomarker Research, 2022, v. 10, n. 1, p. 1, doi. 10.1186/s40364-022-00401-4
- By:
- Publication type:
- Article
Doxorubicin-loaded dextran-based nano-carriers for highly efficient inhibition of lymphoma cell growth and synchronous reduction of cardiac toxicity.
- Published in:
- International Journal of Nanomedicine, 2018, v. 13, p. 5673, doi. 10.2147/IJN.S161203
- By:
- Publication type:
- Article
A novel prognostic model based on four circulating miRNA in diffuse large B‐cell lymphoma: implications for the roles of MDSC and Th17 cells in lymphoma progression.
- Published in:
- Molecular Oncology, 2021, v. 15, n. 1, p. 246, doi. 10.1002/1878-0261.12834
- By:
- Publication type:
- Article
Molecular heterogeneity of BCL2/MYC double expressor lymphoma underlies sensitivity to histone deacetylase inhibitor.
- Published in:
- Clinical & Translational Medicine, 2024, v. 14, n. 6, p. 1, doi. 10.1002/ctm2.1691
- By:
- Publication type:
- Article
CD47 overexpression is related to tumour‐associated macrophage infiltration and diffuse large B‐cell lymphoma progression.
- Published in:
- Clinical & Translational Medicine, 2024, v. 14, n. 1, p. 1, doi. 10.1002/ctm2.1532
- By:
- Publication type:
- Article
Integrative genome‐wide chromatin accessibility and transcriptome profiling of diffuse large B‐cell lymphoma.
- Published in:
- Clinical & Translational Medicine, 2022, v. 12, n. 7, p. 1, doi. 10.1002/ctm2.975
- By:
- Publication type:
- Article
Influence of oncogenic mutations and tumor microenvironment alterations on extranodal invasion in diffuse large B‐cell lymphoma.
- Published in:
- Clinical & Translational Medicine, 2020, v. 10, n. 7, p. 1, doi. 10.1002/ctm2.221
- By:
- Publication type:
- Article
Single-Cell Transcriptome Analysis Identifies Ligand–Receptor Pairs Associated With BCP-ALL Prognosis.
- Published in:
- Frontiers in Oncology, 2021, v. 11, p. N.PAG, doi. 10.3389/fonc.2021.639013
- By:
- Publication type:
- Article
Epigenetic regulation of Epstein–Barr virus: From bench to bedside.
- Published in:
- Clinical & Translational Discovery, 2024, v. 4, n. 5, p. 1, doi. 10.1002/ctd2.357
- By:
- Publication type:
- Article
The Prognostic Significance of CD79B Mutation in Diffuse Large B-Cell Lymphoma: A Meta-analysis and Systematic Literature Review.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2022, v. 22, n. 12, p. e1051, doi. 10.1016/j.clml.2022.08.006
- By:
- Publication type:
- Article
Haptoglobin genotypes and risk of vascular complications in a northern Chinese Han population with type 2 diabetes mellitus.
- Published in:
- International Journal of Diabetes in Developing Countries, 2022, v. 42, n. 3, p. 514, doi. 10.1007/s13410-021-01002-x
- By:
- Publication type:
- Article
Reassessment of the prognostic factors of international prognostic index (IPI) in the patients with diffuse large B-cell lymphoma in an era of R-CHOP in Chinese population.
- Published in:
- Annals of Hematology, 2009, v. 88, n. 9, p. 863, doi. 10.1007/s00277-009-0702-1
- By:
- Publication type:
- Article
Molecular heterogeneity of CD30+ diffuse large B-cell lymphoma with prognostic significance and therapeutic implication.
- Published in:
- 2022
- By:
- Publication type:
- Letter
Genetic variations of DNA repair genes and their prognostic significance in patients with acute myeloid leukemia.
- Published in:
- International Journal of Cancer, 2011, v. 128, n. 1, p. 233, doi. 10.1002/ijc.25318
- By:
- Publication type:
- Article
A novel lncRNA TCLlnc1 promotes peripheral T cell lymphoma progression through acting as a modular scaffold of HNRNPD and YBX1 complexes.
- Published in:
- Cell Death & Disease, 2021, v. 12, n. 4, p. 1, doi. 10.1038/s41419-021-03594-y
- By:
- Publication type:
- Article
Clinical efficacy and molecular biomarkers in a phase II study of tucidinostat plus R-CHOP in elderly patients with newly diagnosed diffuse large B-cell lymphoma.
- Published in:
- Clinical Epigenetics, 2020, v. 12, n. 1, p. N.PAG, doi. 10.1186/s13148-020-00948-9
- By:
- Publication type:
- Article
The effects of ADAM28 on HDPC biological characteristics.
- Published in:
- Shanghai Journal of Stomatology, 2008, v. 17, n. 3, p. 280
- By:
- Publication type:
- Article
Implication of immune cell signature of tumor microenvironment in diffuse large B‐cell lymphoma.
- Published in:
- Hematological Oncology, 2021, v. 39, n. 5, p. 616, doi. 10.1002/hon.2905
- By:
- Publication type:
- Article
Primary extranodal diffuse large B‐cell lymphoma: Molecular features, treatment, and prognosis.
- Published in:
- Aging & Cancer, 2022, v. 3, n. 3/4, p. 133, doi. 10.1002/aac2.12058
- By:
- Publication type:
- Article
Anti-metabolic agent pegaspargase plus PD-1 antibody sintilimab for first-line treatment in advanced natural killer T cell lymphoma.
- Published in:
- Signal Transduction & Targeted Therapy, 2024, v. 9, n. 1, p. 1, doi. 10.1038/s41392-024-01782-8
- By:
- Publication type:
- Article
Improved prediction of chemoresistance in patients with diffuse large B-cell lymphoma through a new interim positron emission tomography-computed tomography evaluation model.
- Published in:
- Acta Oncologica, 2021, v. 60, n. 6, p. 735, doi. 10.1080/0284186X.2021.1894477
- By:
- Publication type:
- Article
Positron emission tomography‐adapted therapy in low‐risk diffuse large B‐cell lymphoma: results of a randomized, phase III, non‐inferiority trial.
- Published in:
- Cancer Communications, 2023, v. 43, n. 8, p. 896, doi. 10.1002/cac2.12462
- By:
- Publication type:
- Article
Human endogenous retroviruses as epigenetic therapeutic targets in TP53-mutated diffuse large B-cell lymphoma.
- Published in:
- Signal Transduction & Targeted Therapy, 2023, v. 8, n. 1, p. 1, doi. 10.1038/s41392-023-01626-x
- By:
- Publication type:
- Article
Simplified algorithm for genetic subtyping in diffuse large B-cell lymphoma.
- Published in:
- Signal Transduction & Targeted Therapy, 2023, v. 8, n. 1, p. 1, doi. 10.1038/s41392-023-01358-y
- By:
- Publication type:
- Article
MicroRNA-221 promotes papillary thyroid carcinoma cells migration and invasion via targeting RECK and regulating epithelial–mesenchymal transition.
- Published in:
- OncoTargets & Therapy, 2019, v. 12, p. 2323, doi. 10.2147/OTT.S190364
- By:
- Publication type:
- Article
Use of Complete Blood Count for Prognostic Evaluation of Peripheral T-Cell Lymphoma.
- Published in:
- Acta Haematologica, 2020, v. 143, n. 2, p. 93, doi. 10.1159/000501353
- By:
- Publication type:
- Article
How we treat NK/T-cell lymphomas.
- Published in:
- Journal of Hematology & Oncology, 2022, v. 15, n. 1, p. 1, doi. 10.1186/s13045-022-01293-5
- By:
- Publication type:
- Article
Therapeutic targeting miR130b counteracts diffuse large B-cell lymphoma progression via OX40/OX40L-mediated interaction with Th17 cells.
- Published in:
- Signal Transduction & Targeted Therapy, 2022, v. 7, n. 1, p. 1, doi. 10.1038/s41392-022-00895-2
- By:
- Publication type:
- Article
CREBBP/EP300 mutations promoted tumor progression in diffuse large B-cell lymphoma through altering tumor-associated macrophage polarization via FBXW7-NOTCH-CCL2/CSF1 axis.
- Published in:
- Signal Transduction & Targeted Therapy, 2021, v. 6, n. 1, p. 1, doi. 10.1038/s41392-020-00437-8
- By:
- Publication type:
- Article
setd2 knockout zebrafish is viable and fertile: differential and developmental stress-related requirements for Setd2 and histone H3K36 trimethylation in different vertebrate animals.
- Published in:
- Cell Discovery, 2020, v. 6, n. 1, p. N.PAG, doi. 10.1038/s41421-020-00203-8
- By:
- Publication type:
- Article
Prognostic factors of Chinese patients with T/NK-cell lymphoma: a single institution study of 170 patients.
- Published in:
- Medical Oncology, 2012, v. 29, n. 3, p. 2176, doi. 10.1007/s12032-011-0011-0
- By:
- Publication type:
- Article
CEOP/IVE/GDP alternating regimen compared with CEOP as the first-line therapy for newly diagnosed patients with peripheral T cell lymphoma: results from a phase 2, multicenter, randomized, controlled clinical trial.
- Published in:
- Genome Medicine, 2020, v. 12, n. 1, p. 1, doi. 10.1186/s13073-020-00739-0
- By:
- Publication type:
- Article